Caldwell Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Caldwell Trust's AZN Position: Q3 2026 in Review
Caldwell Trust increased its AstraZeneca (AZN) stake by 26% in Q3 2026, buying an estimated $367K and bringing the position to 10,658 shares worth $1.72M. The position accounts for 0.14% of the portfolio, ranked #125.
Caldwell Trust first reported a position in AZN in Q4 2019 and has held it in 22 quarters since. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Caldwell Trust held 10,658 shares of AstraZeneca worth $1.72M as of Q3 2026.
- Caldwell Trust bought 2,204 AstraZeneca shares in Q3 2026, an estimated $367K.
- AstraZeneca made up 0.14% of Caldwell Trust's portfolio in Q3 2026, its #125 holding.
- Caldwell Trust first reported a position in AstraZeneca in Q4 2019 and has held it in 22 quarters since.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.